Featured content

What do you need?


Online members portal


ABPI members can log in for bespoke content and services


For the Chance

Millions of people wouldn't be here today if it wasn't for life-changing science. And many more wouldn't be living the lives they do.

Play video


09 July 2019

ABPI response to details of new payment system for antibiotics

The Government has announced further details for how they will support pharmaceutical companies’ investments in the development of drugs that will treat AMR infections.

03 July 2019

ABPI Chief Executive announces retirement

The ABPI's Chief Executive, Mike Thompson, has announced that he is due to retire at the end of 2019.

28 June 2019

Pharmaceutical industry invests £377 million in UK R&D collaborations

New figures published today by the ABPI show that the pharmaceutical industry continues to invest significantly in UK research and development, working with healthcare professionals and organisations to improve care for NHS patients.

26 June 2019

ABPI response to Government 'no deal' guidance

A written ministerial statement from the Cabinet Office has been published this afternoon, along with a letter giving an update on the Government’s 'no deal' planning and guidance.  



20 June 2019

A career in medicines manufacturing means you can help people

Jamie Harvey from AstraZeneca is one of around 40,000 people employed in medicines manufacturing in the UK. He gives his perspective on what it’s like to be an apprentice in the sector.

05 June 2019

Medicines pricing in the UK and access to Cystic Fibrosis medicines

Dr Richard Torbett provides an ABPI view on medicines pricing in the UK and the current situation between NHS England and Vertex on access to Orkambi for Cystic Fibrosis patients